Acadia Pharmaceuticals | ACAD - ДОЛГ





ДОЛГ Изменить Дата
Acadia Pharmaceuticals USD 54.81M 1.48M 2025-09
ALKERMES USD 70M 1.6M 2025-12
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
Biogen USD 6.56B 275.1M 2026-03
BioMarin Pharmaceutical USD 605.86M 1.62M 2025-12
Bristol-Myers Squibb USD 47.14B 3.9B 2025-12
Cara Therapeutics USD 0 0 2025-03
Corcept Therapeutics USD 6.11M 251K 2025-12
Cytokinetics USD 1.28B 87.39M 2025-12
Eisai JPY 236.67B 49.14B 2025-09
Eli Lilly USD 42.5B 3.6M 2025-12
Incyte USD 39.43M 982K 2026-03
J&J USD 47.93B 2.14B 2025-12
Moderna USD 1.31B 571M 2025-12
Neurocrine Biosciences USD 415.3M 13.1M 2025-12
Pfizer USD 63.96B 3.11B 2025-12
Prothena USD 9.08M 699K 2025-09
PTC Therapeutics USD 2.71B 2.42B 2025-12
Sarepta Therapeutics USD 1.25B 103.69M 2025-09
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Vanda Pharmaceuticals USD 4.96M 4.96M 2024-12
Vertex Pharmaceuticals USD 2.03B 195.7M 2025-12